NCT01832467View on ClinicalTrials.gov

Cetuximab Rechallenge Study

PHASE2CompletedINTERVENTIONAL
Enrollment

17

Participants

Timeline

Start Date

April 24, 2013

Primary Completion Date

April 7, 2020

Study Completion Date

April 7, 2020

Conditions
Metastatic Colorectal Cancer
Interventions
DRUG

cetuximab-containing chemotherapy

Trial Locations (1)

Unknown

Department of Clinical Oncology, Prince of Wales Hospital, Hong Kong

All Listed Sponsors
lead

Chinese University of Hong Kong

OTHER

NCT01832467 - Cetuximab Rechallenge Study | Biotech Hunter | Biotech Hunter